A. D. Beadell Investment Counsel Inc. acquired a new position in Grail, Inc. (NASDAQ:GRAL – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 24,138 shares of the company’s stock, valued at approximately $430,000. A. D. Beadell Investment Counsel Inc. owned 0.07% of Grail as of its most recent filing with the Securities and Exchange Commission.
Separately, Douglas Lane & Associates LLC purchased a new position in shares of Grail in the 4th quarter valued at approximately $3,034,000.
Wall Street Analyst Weigh In
Several brokerages have commented on GRAL. Wolfe Research assumed coverage on Grail in a research report on Friday, November 15th. They set a “peer perform” rating for the company. Guggenheim assumed coverage on shares of Grail in a research note on Thursday, October 17th. They set a “neutral” rating on the stock. Finally, Morgan Stanley assumed coverage on shares of Grail in a report on Wednesday, November 27th. They issued an “equal weight” rating and a $16.00 price objective on the stock.
Grail Price Performance
Grail stock traded up $0.04 during mid-day trading on Friday, reaching $17.70. The stock had a trading volume of 198,609 shares, compared to its average volume of 534,286. Grail, Inc. has a one year low of $12.33 and a one year high of $24.92. The company’s 50-day moving average price is $17.88.
Insider Transactions at Grail
In other news, CFO Aaron Freidin sold 30,452 shares of the firm’s stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $14.02, for a total transaction of $426,937.04. Following the sale, the chief financial officer now owns 268,277 shares of the company’s stock, valued at $3,761,243.54. This trade represents a 10.19 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Robert P. Ragusa sold 123,454 shares of the business’s stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of $14.02, for a total transaction of $1,730,825.08. Following the transaction, the chief executive officer now directly owns 612,661 shares of the company’s stock, valued at $8,589,507.22. The trade was a 16.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here.
Grail Company Profile
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
See Also
- Five stocks we like better than Grail
- Insider Trading – What You Need to Know
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- How Investors Can Find the Best Cheap Dividend Stocks
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- What is the Nasdaq? Complete Overview with History
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Grail Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grail and related companies with MarketBeat.com's FREE daily email newsletter.